GHRP-6
GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide that stimulates growth hormone release through activation of the ghrelin receptor (GHS-R1a) and CD36 receptor.
View researchGHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide that stimulates growth hormone release through activation of the ghrelin receptor (GHS-R1a) and CD36 receptor.
View researchHexarelin (also known as Examorelin) is a synthetic hexapeptide growth hormone releasing peptide (GHRP) and one of the most potent GH secretagogues studied.
View researchKisspeptin is a family of neuropeptides encoded by the KISS1 gene that acts as a master regulator of the reproductive system.
View researchMelanotan II is a synthetic analog of alpha-melanocyte-stimulating hormone (α-MSH) that stimulates melanin production for skin tanning and has additional effects on sexual arousal and appetite…
View researchOxytocin is a nine-amino-acid peptide hormone and neuropeptide naturally produced in the hypothalamus and released by the posterior pituitary.
View researchProstamax (Lys-Glu-Asp-Pro/KEDP) is a synthetic tetrapeptide bioregulator from the Khavinson peptide family that demonstrates prostate-specific tissue effects.
View researchPT-141 (Bremelanotide) is an FDA-approved synthetic peptide that acts as a melanocortin receptor agonist, specifically targeting MC3R and MC4R receptors in the central nervous system.
View researchSermorelin acetate is a 29-amino acid synthetic analog of human growth hormone-releasing hormone (GHRH) originally FDA-approved in 1997 for pediatric growth hormone deficiency.
View researchTestagen (KEDG, Lys-Glu-Asp-Gly) is a synthetic tetrapeptide bioregulator developed by Russian scientist Vladimir Khavinson and his team at the St.
View researchTestosterone Replacement Therapy (TRT) is FDA-approved for treating male hypogonadism (low testosterone) caused by testicular failure or hypothalamic-pituitary dysfunction.
View research